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Abstract
Background. Bleeding during liver transection remains a potential hazard. This study aims to report the efficacy and
complications of in-line radiofrequency ablation (ILRFA)-assisted liver resection. Patients and methods. The blood loss of 25
consecutive patients who underwent ILRFA-assisted liver resection was obtained by weighing swabs and measuring suction
jar contents during liver resection and calculated in ml per cm2 of the transection surface area. Postoperative complications
were recorded. Five clinical variables, which might affect blood loss, were analyzed. Results. The mean blood loss during
parenchymal dissection for the ILRFA group was 3.49/3.2 ml/cm2. Three patients had intra-abdominal collections,
including one patient with bile leakage after ILRFA-assisted liver resection. Age, gender, extent of liver resection, liver
quality and Pringle maneuver did not demonstrate significant impact on blood loss. Conclusions. This study showed that
ILRFA-assisted liver resection was associated with very low blood loss. This is likely to improve the operative safety of liver
resection for hepatic tumors. There were no significant postoperative sequelae.
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Introduction
Blood loss during liver resection remains a potential
problem. It has been shown to have a deleterious
impact on both short- and long-term outcomes of
the surgery [1,2]. Median blood loss is reported as
4501500 ml following liver resection, depending on
the extent of resection and the normality of the liver
parenchyma [37]. Perioperative transfusion for
major blood loss is also associated with ad-
verse prognosis in patients who undergo liver resec-
tion [8].
Radiofrequency ablation (RFA) has now been
widely used for in situ destruction of liver tumors.
RF electrical current produces heat, coagulation, and
local tissue necrosis. Some surgeons have described
use of an original RFA needle to create an avascular
area through which the division of the hepatic
parenchyma can be achieved with minimal blood
loss [9,10]. The recently designed in-line radio-
frequency ablation (ILRFA) probe consists of a
plastic body with six deployable electrodes in one
line, which can produce a precise avascular section
up to 5 cm long, 6 cm deep and 1 cm wide. This
transection plane can then be dissected almost
bloodlessly with only a few large vessels and biliary
structures requiring ligation or application of clips
[11,12].
Some other techniques of hepatic resection, such as
microwave coagulation and harmonic scalpel, have
been shown to cause more bile leakage than the
conventional clamp crushing method [9,13]. It is
unknown if the area of necrosis created with ILRFA
would result in a higher incidence of postoperative
bile leakage. With our previous pilot study design, it
was not possible to report on the postoperative
complications associated with ILRFA-assisted liver
resection [12]. In this article, we report the efficacy
and complications of ILRFA-assisted liver resection in
the next 25 consecutive patients with primary or
metastatic liver tumors.
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Patients and methods
The Ethics Committee of SESAHS approved this
study (Approval No: 03/172).
Materials
The ILRFA probe is a 5 cm long plastic device with
six electrodes, spaced along the probe in one line,
each 6 cm long, which can be deployed to varying
depths in the hepatic parenchyma (Figure 1). The
probe is connected to a standard RFA generator
(1500 RITA generator, Sunnyvale, CA, USA). Each
ablation was performed strictly according to the
ILRFA protocol and each ablation cycle was 3 min.
Patient selection
The inclusion criteria for ILRFA-assisted liver resec-
tion were: (1) patients with radiologically or histolo-
gically proven primary or secondary hepatic tumors;
(2) hepatic disease suitable for liver resection; (3)
signed informed consent for ILRFA; (4) age between
18 and 85 years. The exclusion criteria were: (1)
previous hepatic operations; (2) bleeding diathesis
(prothrombin time/1.5 and plateletsB/100/109);
(3) additional procedures planned to the liver, e.g.
cryoablation. A total of 51 patients underwent liver
surgery during the study period; 25 patients who
satisfied both the inclusion and exclusion criteria
underwent ILRFA-assisted liver resection.
Operative procedures
All operations were performed under general anesthe-
sia without central venous pressure (CVP) reduction.
After liver mobilization, intraoperative ultrasound
(IOUS) was performed to confirm the size, number
and location of the hepatic tumors in relation to the
major hepatic veins and the portal sheaths. The plane
of transection was marked with a diathermy on the
surface of the liver.
The IOUS was also used to identify the relationship
of the hepatic veins and the portal sheaths to the
intended transection plane. Under IOUS guidance,
these intraparenchymal structures were avoided dur-
ing the deployment of the ILRFA electrodes, as each
electrode can be independently deployed to varying
depths. All the intended transection planes were
ablated with ILRFA and then transected using an
ultrasonic aspirator (Selector, Integra Neurosciences,
UK). Blood loss during transection was calculated in
ml/cm2, where the amount of blood loss was mea-
sured in milliliters by weighing the sponges and
counting the volume in the suction system, and the
transection area was measured on the specimen in
cm2. In some of the patients, the Pringle maneuver
was applied during the liver resection. The larger
vessels and bile ducts were cauterized, clipped or
ligated according to our routine practice.
All procedures were performed by D.L.M., an
experienced liver surgeon. The clinical information
in this study was collected prospectively by complet-
ing a standardized data sheet for each patient. Patients
were followed at monthly intervals for the first 6
months and then at 3-monthly intervals thereafter.
The assessments included clinical examination, liver
function tests, tumor marker analysis and abdominal
computed tomography (CT).
Statistical analysis
Statistical analysis was performed on the prospectively
collected clinical data. The efficacy of ILRFA in blood
loss was studied. The postoperative complications
were recorded. Wilcoxon rank test was used for the
comparison of difference in means of continuous
factors. The statistical analyses were performed using
SPSS for Windows (Version 11.5; SPSS GmbH,
Munich, Germany). A significant difference was
assumed for p valuesB/0.05.
Results
All operations proceeded as planned. The demo-
graphics of these patients are shown in Table I. There
was no hospital mortality. The mean volume of blood
loss during the liver transection was 2739/325 ml.
Twelve patients had less extensive liver resection (B/3
segments); their absolute volume of blood loss during
liver transection was 35, 50, 50, 50, 87, 150, 205,
245, 295, 300, 305 and 445 ml, respectively; and their
mean volume of blood loss during liver transection
was 1859/135 ml. The remaining 13 patients had
more extensive liver transection (]/ 3 segments); their
absolute volume of blood loss during liver transection
was 50, 60, 80, 95, 100, 105, 200, 210, 350, 350,
605, 895 and 1500 ml, respectively; and their mean
volume of blood loss was 3549/425 ml (p/0.300, vs
B/3 segments). The mean volume of blood loss per
cm2 was 3.49/3.2. Seven patients (28%) had at leastFigure 1. In-line radiofrequency ablation (ILRFA) probe.
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one unit of intraoperative blood transfusion and the
average unit of transfusion given was 0.6 units per
patient. There were 15 patients (60%) with normal
liver, 8 patients (32%) with steatotic liver and 2
patients (8%) with cirrhotic livers. The blood loss of
the two cirrhotic patients was 2.5 and 3.3 ml/cm2,
respectively. The blood loss of the eight steatotic
patients was 1, 1.2, 1.2, 1.3, 1.7, 2.0, 5.0, and 15.0
ml/cm2, respectively. The mean operative time was
1699/58 min. The mean postoperative stay was 79/4
days. The median follow-up was 4 months (range 1
11 months).
The impact of five variables that might potentially
affect blood loss during ILRFA-assisted liver transec-
tion is demonstrated in Table II. They are gender, age
(B/60 vs]/60 years), liver quality (normal vs steatotic
and cirrhotic), extent of resection (B/3 segments vs ]/
3 segments), and Pringle maneuver application. None
of the five factors demonstrated any significant impact
on blood loss during ILRFA-assisted liver transection.
Eleven patients (44%) had the Pringle maneuver
applied during the liver resection, but it was used
only selectively in difficult cases. The average duration
of clamping was 19 min. This maneuver failed
to show statistically significant impact on blood loss
(p/0.632).
Three patients had postoperative intra-abdominal
collections; including one patient who had a bile
collection. All these patients were managed with CT-
guided drain insertion. The median interval between
the operation and the complication was 5 days (range
220 days). There were no other postoperative
complications detected at the last follow-up.
Discussion
Studies show that 2060% of patients undergoing
liver resection require blood transfusion [6,14]. In
patients with cirrhotic livers, bleeding is a more
significant issue. Both short- and long-term morbidity
and mortality correlate with intraoperative blood loss
[1,2]. The more recent study from the Memorial
Sloan-Kettering group reported an estimated blood
loss of 8719/24 ml, a transfusion rate of 49%, a mean
in-flow occlusion time of 31 min, and a mean
transfusion of four units. Blood loss in patients who
died was nearly three times greater [4].
Over the years, different techniques have been
described to minimize blood loss during the transec-
tion phase. Surgeons use low CVP anesthesia, con-
tinuous or intermittent Pringle maneuver or total
vascular exclusion in trying to achieve better operative
results. Parenchymal transection can be performed
with finger fracture, a scalpel or the more refined
ultrasonic aspirator, which disaggregates and sucks
away the soft hepatic parenchymal tissues, leaving the
larger and tougher vessels and ductal structures
behind for ligation or clipping. Rau et al. reported a
blood loss of 24.3 ml/cm2 of resection surface using
the ultrasonic aspirator [15]. In cirrhotic livers, due to
dense fibrosis, the ultrasonic aspirators are less
effective in dividing the parenchymal tissue without
bleeding [15]. Water-jet cutters (hydrodissectors)
have also been used and 17.7 ml/cm2 of blood loss
has been reported [15]. However, early postoperative
bleeding and bile leakage still exist, probably because
of inadequate ligation of small vessels or bile ducts
after segregation of the plane with these devices.
Habib and co-workers first described the use of an
unmodified RFA probe to create a 2 cm zone of
necrosis by repeatedly ablating tissue in the transec-
Table II. Five factors that potentially affect blood loss during
ILRFA-assisted liver transection.
Clinical factor No.
Blood loss (ml/cm2)
Mean9/SD p value*
Overall 25 3.49/ 3.2 
Gender   0.379
Male 16 3.99/3.7 
Female 9 2.59/2.0 
Age (years)   0.739
B/60 10 4.09/4.4 
]/ 60 15 3.09/2.2 
Liver quality   0.523
Normal 15 3.49/2.5 
Steatotic/cirrhotic 10 3.49/4.3 
Extent of resection   0.531
B/3 segments 12 3.49/2.7 
]/3 segments 13 3.49/3.7 
In-flow occlusion   0.632
No 14 3.79/2.5 
Yes 11 3.09/4.0 
*Wilcoxon rank test for the comparison of difference in means of
blood loss.
Table I. Patient characteristics (n/25).
Clinical factor No. of patients %
Overall 25 100
Gender  
Male 16 64
Female 9 36
Age (years)  
B/60 10 40
]/60 15 60
Liver quality  
Normal 15 60
Steatotic 8 32
Cirrhotic 2 8
Resection type*  
Right hepatectomy 8 32
Left hepatectomy 2 8
Extended left hepatectomy 1 4
Left lobectomy 5 20
Segmental resection 9 36
In-flow occlusion  
No 14 56
Yes 11 44
Blood transfusion  
No 18 72
Yes 7 28
*Terminology of Couinaud, 1957.
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tion plane, followed by parenchymal dissection with a
surgical scalpel [9]. They showed very encouraging
results. The mean blood loss was 309/10 ml and no
morbidity or mortality was observed [9]. However,
the major concern with this approach is that it is
relatively slow, requiring many ablations to cover the
intended transection plane, and the spherical abla-
tions are not ideal for developing a coagulative
transection plane. Multiple independent ablations
have to be used, and this can be time-consuming. In
addition, to achieve an adequate transection plane
with this unmodified RFA probe, surgeons sometimes
have to sacrifice more normal liver tissue, which can
be problematic in cirrhotics and in complex liver
resections [10].
This study reports the preliminary results of an
innovative procedure using ILRFA to assist liver
resection. In a sheep model, we have demonstrated
that ILRFA could produce an avascular plane up to 6
cm deep and 5 cm long [11]. Dissection or cutting
through this area was then achieved with minimal, if
any, blood loss. We have also demonstrated a sig-
nificant difference in blood loss (p/0.004) in a pilot
study of eight patients, who had ILRFA for half of the
transection plane and the other half was transected
using a conventional ultrasonic aspirator alone [12].
The major advantages of ILRFA are that it is very
precise and rapid. Each ILRFA electrode should be
deployed individually, under the guidance of intrao-
perative ultrasound, to avoid penetrating any major
vessels (Figure 2). The RF field created between
electrodes of alternating polarity results in localized
heating and coagulation of tissue including blood
vessels up to approximately 3 mm. The ILRFA probe
can be withdrawn and re-applied along the intended
transection plane (Figure 3). Each RF ablation
requires only 3 min to achieve a complete coagulative
ablation. This ablated plane can then be dissected
almost bloodlessly with an ultrasonic aspirator (Figure
4). The small blood vessels and biliary structures are
coagulated in the process and the larger ones are
ligated or clipped.
In this study, the mean blood loss was 3.49/3.2 ml/
cm2. The results are lower than those in our previous
pilot study, perhaps due to our increased experience
[12]. The blood loss of the two cirrhotic patients was
2.5 and 3.3 ml/cm2, respectively, and there were
another two cirrhotics in our pilot study [12]. It is
difficult to draw conclusions from such a small
number of patients, but it is most encouraging that
ILRFA appears to work very effectively in this difficult
group of patients.
Some other techniques of hepatic resection, such as
microwave coagulation and harmonic scalpel, have
been shown to cause more bile leakage than the
conventional clamp crushing method [9,13]. One of
the concerns, however, which our previous study was
unable to address, was the incidence of bile leakage
after ILRFA [12]. In the present study, one patient
had biliary leakage and there was no other significant
postoperative sequela.
Figure 2. In-line radiofrequency ablation (ILRFA) probe deploy-
ment prior to ablation.
Figure 3. In-line radiofrequency ablation (ILRFA) creating a
coagulated section up to 5 cm long, 6 cm deep and 1 cm wide
prior to liver resection.
Figure 4. Avascular transection surface after in-line radiofrequency
ablation (ILRFA)-assisted liver resection.
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This procedure is easy to learn and surgeons with a
good knowledge of liver anatomy can apply it to both
segmental and formal resections. We have used this
technique in both major and minor liver resections.
The extent of liver transection did not affect blood
loss in this study (p/0.531). However, its most
important limitation is that the radiofrequency energy
will ablate any tissue that it is deployed through.
Therefore it is of great importance not to damage
hepatic veins or portal sheaths to the liver, which are
to be retained. To avoid this, we recommend the use
of intraoperative ultrasound during the electrode
deployment.
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